Korenchuk S - Search Results

1

Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, Korenchuk S, Pienta KJ. Rubin MA, et al. Among authors: korenchuk s. Clin Cancer Res. 2000 Mar;6(3):1038-45. Clin Cancer Res. 2000. PMID: 10741732

2

Treatment of androgen-independent prostate cancer using antimicrotubule agents docetaxel and estramustine in combination: an experimental study.

Williams JF, Muenchen HJ, Kamradt JM, Korenchuk S, Pienta KJ. Williams JF, et al. Among authors: korenchuk s. Prostate. 2000 Sep 1;44(4):275-8. doi: 10.1002/1097-0045(20000901)44:4<275::aid-pros3>3.0.co;2-9. Prostate. 2000. PMID: 10951491 Free article.

3

VCaP, a cell-based model system of human prostate cancer.

Korenchuk S, Lehr JE, MClean L, Lee YG, Whitney S, Vessella R, Lin DL, Pienta KJ. Korenchuk S, et al. In Vivo. 2001 Mar-Apr;15(2):163-8. In Vivo. 2001. PMID: 11317522

4

Establishment and characterization of a new human prostatic cancer cell line: DuCaP.

Lee YG, Korenchuk S, Lehr J, Whitney S, Vessela R, Pienta KJ. Lee YG, et al. Among authors: korenchuk s. In Vivo. 2001 Mar-Apr;15(2):157-62. In Vivo. 2001. PMID: 11317521

5

MIM, a potential metastasis suppressor gene in bladder cancer.

Lee YG, Macoska JA, Korenchuk S, Pienta KJ. Lee YG, et al. Among authors: korenchuk s. Neoplasia. 2002 Jul-Aug;4(4):291-4. doi: 10.1038/sj.neo.7900231. Neoplasia. 2002. PMID: 12082544 Free PMC article.

6

Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase.

Sabbatini P, Rowand JL, Groy A, Korenchuk S, Liu Q, Atkins C, Dumble M, Yang J, Anderson K, Wilson BJ, Emmitte KA, Rabindran SK, Kumar R. Sabbatini P, et al. Among authors: korenchuk s. Clin Cancer Res. 2009 May 1;15(9):3058-67. doi: 10.1158/1078-0432.CCR-08-2530. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383820

7

Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.

Wyce A, Degenhardt Y, Bai Y, Le B, Korenchuk S, Crouthame MC, McHugh CF, Vessella R, Creasy CL, Tummino PJ, Barbash O. Wyce A, et al. Among authors: korenchuk s. Oncotarget. 2013 Dec;4(12):2419-29. doi: 10.18632/oncotarget.1572. Oncotarget. 2013. PMID: 24293458 Free PMC article.

8

GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers.

Sabbatini P, Korenchuk S, Rowand JL, Groy A, Liu Q, Leperi D, Atkins C, Dumble M, Yang J, Anderson K, Kruger RG, Gontarek RR, Maksimchuk KR, Suravajjala S, Lapierre RR, Shotwell JB, Wilson JW, Chamberlain SD, Rabindran SK, Kumar R. Sabbatini P, et al. Among authors: korenchuk s. Mol Cancer Ther. 2009 Oct;8(10):2811-20. doi: 10.1158/1535-7163.MCT-09-0423. Mol Cancer Ther. 2009. PMID: 19825801

9

Mechanism and management of AKT inhibitor-induced hyperglycemia.

Crouthamel MC, Kahana JA, Korenchuk S, Zhang SY, Sundaresan G, Eberwein DJ, Brown KK, Kumar R. Crouthamel MC, et al. Among authors: korenchuk s. Clin Cancer Res. 2009 Jan 1;15(1):217-25. doi: 10.1158/1078-0432.CCR-08-1253. Clin Cancer Res. 2009. PMID: 19118049

10

BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models.

Wyce A, Ganji G, Smitheman KN, Chung CW, Korenchuk S, Bai Y, Barbash O, Le B, Craggs PD, McCabe MT, Kennedy-Wilson KM, Sanchez LV, Gosmini RL, Parr N, McHugh CF, Dhanak D, Prinjha RK, Auger KR, Tummino PJ. Wyce A, et al. Among authors: korenchuk s. PLoS One. 2013 Aug 23;8(8):e72967. doi: 10.1371/journal.pone.0072967. eCollection 2013. PLoS One. 2013. PMID: 24009722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters